Columbus, Ohio 43210

  • Refractory Leukemia

Purpose:

This trial investigates how well bright white light therapy works in improving sleep, fatigue, distress, depression, and anxiety, side effects that are often experienced during an intense leukemia treatment regimen, in hospitalized leukemia patients. Bright white light therapy may help to control these symptoms, and information from this study may help doctors and nurses learn more about methods for decreasing these symptoms.


Study summary:

PRIMARY OBJECTIVE: I. To assess the efficacy of bright white light therapy (BWLT) on fatigue in patients diagnosed with leukemia during their hospitalization. SECONDARY OBJECTIVES: I. To assess the efficacy of BWLT on sleep disturbance in patients diagnosed with leukemia during their hospitalization. I. To assess the efficacy of BWLT on anxiety in patients diagnosed with leukemia during their hospitalization. III. To assess the efficacy of BWLT on depression in patients diagnosed with leukemia during their hospitalization. IV. To assess the efficacy of BWLT on distress in patients diagnosed with leukemia during their hospitalization. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients receive BWLT over 30 minutes in addition to standard of care daily during hospital stay. GROUP II: Patients receive standard of care during hospital stay.


Criteria:

Inclusion Criteria: - Admitted to the Acute Leukemia Unit for an anticipated stay of 3 weeks or longer - English speaking - Able to comprehend and sign a consent form - Able to read and complete surveys - Alert and oriented - Without BWLT for seven days prior to initiating the trial Exclusion Criteria: - Current eye disorders which is defined as: - Iritis, uveitis, keratitis, cataract, glaucoma, macular degeneration, retinal detachment, or retinitis pigmentosa - Diagnosed bipolar disorder - Persons with pacemakers - The manufacturer of the BWLT unit used for this study mentions the light unit contains magnets


NCT ID:

NCT04597086


Primary Contact:

Principal Investigator
Shelly Brown, MS, APRN-CNS
Ohio State University Comprehensive Cancer Center

The Ohio State University Comprehensive Cancer Center
Phone: 800-293-5066
Email: OSUCCCClinicaltrials@osumc.edu


Backup Contact:

N/A


Location Contact:

Columbus, Ohio 43210
United States

Shelly Brown, MS, APRN-CNS
Phone: 614-293-2598
Email: shelly.brown@osumc.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 28, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.